Table 3.
Treatment groups | Initial mean body weight (g) | Final mean body weight (g) | Change in mean body weight (g) | % change in mean body weight |
---|---|---|---|---|
Control | 182.851 ± 10.39 | 274.448 ± 9.125 | 91.60 ± 9.002 | 50.1 |
Model | 196.074 ± 7.245 | 224.990 ± 4.093 | 28.92 ± 8.357# | 14.74 |
Carvedilol | 174.803 ± 5.39 | 227.275 ± 3.224 | 52.472 ± 4.624∗ | 30.01 |
aTween20 | 177.005 ± 3.689 | 209.336 ± 4.579 | 32.331 ± 6.353∗ | 18.26 |
| ||||
ZZAE (mg/kg) | ||||
50 | 182.446 ± 7.576 | 239.648 ± 6.397 | 57.202 ± 7.788∗ | 31.35 |
100 | 177.121 ± 3.58 | 242.089 ± 9.771 | 64.968 ± 9.753∗ | 36.68 |
200 | 184.874 ± 3.331 | 233.421 ± 4.243 | 48.547 ± 3.24∗ | 26.26 |
# P ≤ 0.05 (control versus model groups); ∗P ≤ 0.05 (model versus all other treatment groups); a(vehicle, 1 mL/rat, once daily).